Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20171
20191
20201
20222
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
BioNTech SE1
Blue Earth Therapeutics Ltd1
Central European Society for Anticancer Drug Research1
CureVac1
German Cancer Research Center1
Novartis Pharmaceuticals1
PMV Pharmaceuticals, Inc1
SpectraCure AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms10
Breast Neoplasms3
Neoplasm Metastasis2
Ovarian Neoplasms2
Astrocytoma1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Endometrial Neoplasms1
Fallopian Tube Neoplasms1
Gallbladder Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.